Mary‐Anne Hartley

1.8k total citations
38 papers, 1.0k citations indexed

About

Mary‐Anne Hartley is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Epidemiology. According to data from OpenAlex, Mary‐Anne Hartley has authored 38 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Public Health, Environmental and Occupational Health, 14 papers in Infectious Diseases and 8 papers in Epidemiology. Recurrent topics in Mary‐Anne Hartley's work include Research on Leishmaniasis Studies (13 papers), Viral Infections and Vectors (7 papers) and Trypanosoma species research and implications (7 papers). Mary‐Anne Hartley is often cited by papers focused on Research on Leishmaniasis Studies (13 papers), Viral Infections and Vectors (7 papers) and Trypanosoma species research and implications (7 papers). Mary‐Anne Hartley collaborates with scholars based in Switzerland, United States and Tanzania. Mary‐Anne Hartley's co-authors include Catherine Ronet, Nicolás Fasel, Stephen M. Beverley, Haroun Zangger, Patrik Castiglioni, Florence Prével, Chantal Desponds, Stefan K. Drexler, Matteo A. C. Rossi and Remzi Onur Eren and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mary‐Anne Hartley

36 papers receiving 997 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary‐Anne Hartley Switzerland 19 675 407 257 121 103 38 1.0k
Joy Gary United States 15 552 0.8× 403 1.0× 884 3.4× 20 0.2× 111 1.1× 32 1.4k
Inès Vigan-Womas France 20 685 1.0× 144 0.4× 94 0.4× 154 1.3× 394 3.8× 55 1.1k
Fredric I. Weinbaum United States 17 447 0.7× 201 0.5× 80 0.3× 170 1.4× 349 3.4× 31 938
Alejandro Escobar‐Gutiérrez Mexico 20 194 0.3× 376 0.9× 415 1.6× 43 0.4× 176 1.7× 66 1.0k
Artur T. L. Queiroz Brazil 15 258 0.4× 388 1.0× 327 1.3× 40 0.3× 111 1.1× 76 917
Sally Caglioti United States 16 580 0.9× 826 2.0× 710 2.8× 84 0.7× 41 0.4× 18 1.6k
David E. Krysztof United States 20 846 1.3× 709 1.7× 906 3.5× 110 0.9× 172 1.7× 35 1.8k
Bráulia Costa Caetano Brazil 17 349 0.5× 613 1.5× 160 0.6× 268 2.2× 207 2.0× 33 939
Henda Triki Tunisia 20 376 0.6× 934 2.3× 1.0k 3.9× 52 0.4× 117 1.1× 102 1.8k
Ajay Bhatia United States 18 737 1.1× 653 1.6× 147 0.6× 184 1.5× 166 1.6× 43 1.3k

Countries citing papers authored by Mary‐Anne Hartley

Since Specialization
Citations

This map shows the geographic impact of Mary‐Anne Hartley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary‐Anne Hartley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary‐Anne Hartley more than expected).

Fields of papers citing papers by Mary‐Anne Hartley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary‐Anne Hartley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary‐Anne Hartley. The network helps show where Mary‐Anne Hartley may publish in the future.

Co-authorship network of co-authors of Mary‐Anne Hartley

This figure shows the co-authorship network connecting the top 25 collaborators of Mary‐Anne Hartley. A scholar is included among the top collaborators of Mary‐Anne Hartley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary‐Anne Hartley. Mary‐Anne Hartley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karami, Hojat, et al.. (2025). TimEHR: Image-Based Time Series Generation for Electronic Health Records. IEEE Journal of Biomedical and Health Informatics. 29(12). 9170–9180.
2.
Ruchonnet-Métrailler, Isabelle, Johan N Siebert, Mary‐Anne Hartley, & Laurence Lacroix. (2024). Automated Interpretation of Lung Sounds by Deep Learning in Children With Asthma: Scoping Review and Strengths, Weaknesses, Opportunities, and Threats Analysis. Journal of Medical Internet Research. 26. e53662–e53662. 4 indexed citations
3.
Karimireddy, Sai Praneeth, et al.. (2024). MyThisYourThat for interpretable identification of systematic bias in federated learning for biomedical images. npj Digital Medicine. 7(1). 238–238.
4.
Suttels, Véronique, Elena Ramı́rez, Mary‐Anne Hartley, et al.. (2023). Barriers and facilitators to implementation of point-of-care lung ultrasonography in a tertiary centre in Benin: a qualitative study among general physicians and pneumologists. BMJ Open. 13(6). e070765–e070765. 6 indexed citations
5.
Hartley, Mary‐Anne, Jean-Baptiste Cordonnier, Olivier Pantet, et al.. (2022). Point-of-care lung ultrasonography for early identification of mild COVID-19: a prospective cohort of outpatients in a Swiss screening center. BMJ Open. 12(6). e060181–e060181. 1 indexed citations
6.
Laubscher, Florian, Mary‐Anne Hartley, Laurent Kaiser, & Samuel Cordey. (2022). Genomic Diversity of Torque Teno Virus in Blood Samples from Febrile Paediatric Outpatients in Tanzania: A Descriptive Cohort Study. Viruses. 14(8). 1612–1612. 8 indexed citations
7.
Posa, F., et al.. (2022). What If…? Pandemic policy-decision-support to guide a cost-benefit-optimised, country-specific response. SHILAP Revista de lepidopterología. 2(8). e0000721–e0000721. 2 indexed citations
8.
Hartley, Mary‐Anne, Aymeric Cantais, Delphine S. Courvoisier, et al.. (2021). Deep learning diagnostic and risk-stratification pattern detection for COVID-19 in digital lung auscultations: clinical protocol for a case–control and prospective cohort study. BMC Pulmonary Medicine. 21(1). 103–103. 17 indexed citations
9.
Meuwly, Jean‐Yves, et al.. (2020). Lung Ultrasonography for Risk Stratification in Patients with Coronavirus Disease 2019 (COVID-19): A Prospective Observational Cohort Study. Clinical Infectious Diseases. 73(11). e4189–e4196. 38 indexed citations
10.
Laubscher, Florian, Samuel Cordey, Mary‐Anne Hartley, et al.. (2019). Nearly Complete Genome Sequence of a Novel Phlebovirus-Like Virus Detected in a Human Plasma Sample by High-Throughput Sequencing. Microbiology Resource Announcements. 8(35). 4 indexed citations
11.
Hartley, Mary‐Anne, Remzi Onur Eren, Matteo A. C. Rossi, et al.. (2018). Leishmania guyanensis parasites block the activation of the inflammasome by inhibiting maturation of IL-1β. Microbial Cell. 5(3). 137–149. 29 indexed citations
12.
Rossi, Matteo A. C., Patrik Castiglioni, Mary‐Anne Hartley, et al.. (2017). Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis. Proceedings of the National Academy of Sciences. 114(19). 4987–4992. 75 indexed citations
13.
Parihar, Suraj P., Mary‐Anne Hartley, Ramona Hurdayal, Reto Guler, & Frank Brombacher. (2016). Topical Simvastatin as Host-Directed Therapy against Severity of Cutaneous Leishmaniasis in Mice. Scientific Reports. 6(1). 35 indexed citations
14.
Parmentier, Laurent, Alexia Cusini, Norbert Müller, et al.. (2016). Severe Cutaneous Leishmaniasis in a Human Immunodeficiency Virus Patient Coinfected with Leishmania braziliensis and Its Endosymbiotic Virus. American Journal of Tropical Medicine and Hygiene. 94(4). 840–843. 21 indexed citations
15.
Bourreau, Eliane, Marine Ginouvès, Ghislaine Prévot, et al.. (2015). Presence ofLeishmaniaRNA Virus 1 inLeishmania guyanensisIncreases the Risk of First-Line Treatment Failure and Symptomatic Relapse. The Journal of Infectious Diseases. 213(1). 105–111. 111 indexed citations
16.
Schuster, Steffen, Mary‐Anne Hartley, Fabienne Tacchini‐Cottier, & Catherine Ronet. (2014). A scoring method to standardize lesion monitoring following intra-dermal infection of Leishmania parasites in the murine ear. Frontiers in Cellular and Infection Microbiology. 4. 67–67. 20 indexed citations
17.
Ives, Annette, Slavica Masina, Patrik Castiglioni, et al.. (2014). MyD88 and TLR9 Dependent Immune Responses Mediate Resistance to Leishmania guyanensis Infections, Irrespective of Leishmania RNA Virus Burden. PLoS ONE. 9(5). e96766–e96766. 31 indexed citations
18.
Hartley, Mary‐Anne, Catherine Ronet, & Nicolás Fasel. (2012). Backseat drivers: the hidden influence of microbial viruses on disease. Current Opinion in Microbiology. 15(4). 538–545. 11 indexed citations
19.
Hartley, Mary‐Anne, Catherine Ronet, Haroun Zangger, Stephen M. Beverley, & Nicolás Fasel. (2012). Leishmania RNA virus: when the host pays the toll. Frontiers in Cellular and Infection Microbiology. 2. 99–99. 121 indexed citations
20.
Roberts, Helen Clare, et al.. (2011). International disease monitoring, April to June 2011. Veterinary Record. 169(5). 118–121. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026